Home
       
STOCK MARKETS


Back

10 Last viewed shares   
 
Business Segments
  Business Segments
  BRACING AND SUPPORTS Össur’s bracing and supports products are used primarily to support joints and other body parts for therapeutic and preventative ...
  Read more... 
Strategy & Goals
  Strategy & Goals
  Corporate Strategy Össur’s vision is to be the leading company in non-invasive orthopaedics. Össur’s business is improving people’s mobility through ...
  Read more... 
Company Presentation
  Company Presentation
  Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving ...
  Read more... 
   

Carl Zeiss Meditec AG

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer

SHARE DATA GRAPH TECHNICAL ANALYSIS
Select class of Share
Carl Zeiss Meditec (FRK)‎  
Last 62,05      Change % -4,24 
Add to Portfolio
Add to Watchlist
Add to Alerts

10 LAST TRADES EUR
Time Last Volume
Displayed time is based on the time zone of your choice on Euroland.com
Refresh
ChartImage
 
QUOTES EUR
Time 2024-07-16
Last 62,05
Change % -4,24 
Change -2,75 
Bid/Ask 62,05 / 62,55
Open 64,15
High/Low 64,35 / 62,00
Volume 1 004
Previous Close 64,80
52 Weeks High 123,00
52 Weeks Low 63,10
52 Weeks %   -35,20 
YTD %   -34,26 
Volatility 46,25
Beta 0,93
Correlation 0,41
MARKET DATA
Symbol AFX
Market  Frankfurt
List  Prime Standard
Domestic Industry  Pharmaceutical & Healthcare
Euroland-Industry  Medical technology & supplies
Shares (mil)1 89,44
Market Cap (mil) 5 795,75
1 - Number of shares in specific class of share. Otherwise it is total number of shares issued.

INDICES
 MDAX
 SDAX
 Technology All Share
 HDAX
 TecDAX
 Prime All Share

Data delayed at least 15 minutes. From Hanoi & HoChiMinh data is real time. From Milan, Dublin & Tokyo data is as end of day.
Data provided by vwd group Switzerland AG & MOEX.

 
 
   Privacy Policy | Disclaimer | Set this page as your homepage| © Euroland.com 2000-2024